Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
Zachary S. Buchwald, Jacob Wynne, Tahseen H. Nasti, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 359
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Sean McBride, Eric J. Sherman, C. Jillian Tsai, et al.
Journal of Clinical Oncology (2020) Vol. 39, Iss. 1, pp. 30-37
Open Access | Times Cited: 330
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
Vivek Verma, Rajeev Shrimali, Shamim Ahmad, et al.
Nature Immunology (2019) Vol. 20, Iss. 9, pp. 1231-1243
Open Access | Times Cited: 264
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
Sandra Demaria, Chandan Guha, Jonathan D. Schoenfeld, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002038-e002038
Open Access | Times Cited: 199
Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Mauro Krampera, Katarina Le Blanc
Cell stem cell (2021) Vol. 28, Iss. 10, pp. 1708-1725
Closed Access | Times Cited: 172
Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses
Joyce Wei, Welby Montalvo-Ortiz, Lola Yu, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 109
Spatially fractionated radiation therapy: History, present and the future
Weisi Yan, Mohammad K. Khan, Xiaodong Wu, et al.
Clinical and Translational Radiation Oncology (2019) Vol. 20, pp. 30-38
Open Access | Times Cited: 130
Dendritic Cells and Cancer: From Biology to Therapeutic Intervention
Ben Wylie, Christophe Macri, Justine D. Mintern, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 521-521
Open Access | Times Cited: 124
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
Yun Hua Lee, David Tai, Connie Yip, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 116
Abscopal effect in radioimmunotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106663-106663
Closed Access | Times Cited: 112
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
Giuseppe Minniti, Dimitri Anzellini, C. Reverberi, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 106
The Abscopal Effect of Radiation Therapy
Daniel J. Craig, Nisha S. Nanavaty, Monika Devanaboyina, et al.
Future Oncology (2021) Vol. 17, Iss. 13, pp. 1683-1694
Open Access | Times Cited: 92
Radiation-induced small extracellular vesicles as “carriages” promote tumor antigen release and trigger antitumor immunity
Wanzun Lin, Yanyan Xu, Xiaochuan Chen, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 4871-4884
Open Access | Times Cited: 78
The Technical and Clinical Implementation of LATTICE Radiation Therapy (LRT)
Xiaodong Wu, Naipy Pérez, Yi Zheng, et al.
Radiation Research (2020) Vol. 194, Iss. 6
Open Access | Times Cited: 71
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results
Wenya Linda Bi, Lakshmi Nayak, David M. Meredith, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 1, pp. 101-113
Open Access | Times Cited: 61
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Big and Intriguing Challenge Which May Be Resolved by Integrated Treatments Combining Locoregional and Systemic Therapies
Franco Ionna, Paolo Bossi, Agostino Guida, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2371-2371
Open Access | Times Cited: 59
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Richard L. Wahl, George Sgouros, Amir Iravani, et al.
Journal of Nuclear Medicine (2021) Vol. 62, Iss. Supplement 3, pp. 23S-35S
Open Access | Times Cited: 58
Combined High-Dose LATTICE Radiation Therapy and Immune Checkpoint Blockade for Advanced Bulky Tumors: The Concept and a Case Report
Liuqing Jiang, Xiaobo Li, Jianping Zhang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 57
Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice
Heng Zhou, Chen Tu, Pengfei Yang, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 57
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial
Saskia A. Cooke, Dirk De Ruysscher, Bart Reymen, et al.
Radiotherapy and Oncology (2023) Vol. 181, pp. 109492-109492
Open Access | Times Cited: 36
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
Sergio Pannunzio, Armando Di Bello, Denis Occhipinti, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 9
Hyperthermia and immunotherapy: clinical opportunities
Mark Hurwitz
International Journal of Hyperthermia (2019) Vol. 36, Iss. sup1, pp. 4-9
Open Access | Times Cited: 65
Early experience using salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy
Brandon S. Imber, Michel Sadelain, Carl J. DeSelm, et al.
British Journal of Haematology (2020) Vol. 190, Iss. 1, pp. 45-51
Open Access | Times Cited: 64
Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation
Minhui Chen, Guanxi Qiao, Bonnie L. Hylander, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 64
Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy
Michael-Joseph Gorbet, Ashish Ranjan
Pharmacology & Therapeutics (2019) Vol. 207, pp. 107456-107456
Open Access | Times Cited: 62
Page 1 - Next Page

Scroll to top